146 related articles for article (PubMed ID: 1463527)
1. Comparison of loracarbef (LY163892) versus amoxicillin in the treatment of bronchopneumonia and lobar pneumonia.
Müller O; Wettich K
Infection; 1992; 20(3):176-82. PubMed ID: 1463527
[TBL] [Abstract][Full Text] [Related]
2. Loracarbef (LY163892) versus amoxicillin/clavulanate in bronchopneumonia and lobar pneumonia.
Hyslop DL; Jacobson K; Guerra FJ
Clin Ther; 1992; 14(2):254-67. PubMed ID: 1611648
[TBL] [Abstract][Full Text] [Related]
3. Loracarbef (LY163892) versus amoxicillin/clavulanate in the treatment of acute bacterial exacerbations of chronic bronchitis.
Zeckel ML; Jacobson KD; Guerra FJ; Therasse DG; Farlow D
Clin Ther; 1992; 14(2):214-29. PubMed ID: 1611645
[TBL] [Abstract][Full Text] [Related]
4. Loracarbef (LY163892) versus amoxicillin/clavulanate in the treatment of acute purulent bacterial bronchitis.
Dere WH; Farlow D; Therasse DG; Jacobson KD; Guerra FJ
Clin Ther; 1992; 14(2):166-77. PubMed ID: 1611641
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of loracarbef in the treatment of pneumonia.
Hyslop DL
Am J Med; 1992 Jun; 92(6A):65S-69S. PubMed ID: 1621747
[TBL] [Abstract][Full Text] [Related]
6. Loracarbef (LY163892) versus amoxicillin-clavulanate in the treatment of bacterial acute otitis media with effusion.
Foshee WS
J Pediatr; 1992 Jun; 120(6):980-6. PubMed ID: 1593361
[TBL] [Abstract][Full Text] [Related]
7. Loracarbef (LY163892) versus cefaclor in the treatment of bacterial skin and skin-structure infections in an adult population.
McCarty J; Ruoff GE; Jacobson KD
Am J Med; 1992 Jun; 92(6A):80S-85S. PubMed ID: 1621751
[TBL] [Abstract][Full Text] [Related]
8. Comparative evaluation of loracarbef and amoxicillin-clavulanate for acute otitis media.
Gan VN; Kusmiesz H; Shelton S; Nelson JD
Antimicrob Agents Chemother; 1991 May; 35(5):967-71. PubMed ID: 1854178
[TBL] [Abstract][Full Text] [Related]
9. Loracarbef (LY 163892) vs amoxicillin/clavulanate in bacterial maxillary sinusitis.
Sydnor TA; Scheld WM; Gwaltney J; Nielsen RW; Huck W; Therasse DG
Ear Nose Throat J; 1992 May; 71(5):225-32. PubMed ID: 1505371
[TBL] [Abstract][Full Text] [Related]
10. Loracarbef (LY163892) versus cefaclor and norfloxacin in the treatment of uncomplicated pyelonephritis.
Hyslop DL; Bischoff W
Am J Med; 1992 Jun; 92(6A):86S-94S. PubMed ID: 1621752
[TBL] [Abstract][Full Text] [Related]
11. Loracarbef versus penicillin V in the treatment of streptococcal pharyngitis and tonsillitis.
Müller O; Spirer Z; Wettich K
Infection; 1992; 20(5):301-8. PubMed ID: 1428189
[TBL] [Abstract][Full Text] [Related]
12. Loracarbef (LY163892) in the treatment of acute exacerbations of chronic bronchitis: results of U.S. and European comparative clinical trials.
Zeckel ML
Am J Med; 1992 Jun; 92(6A):58S-64S. PubMed ID: 1621746
[TBL] [Abstract][Full Text] [Related]
13. Loracarbef versus penicillin VK in the treatment of streptococcal pharyngitis and tonsillitis in adults.
McCarty J; Hernon Y; Linn L; Therasse DG; Molina A; Bleile N
Clin Ther; 1992; 14(1):30-40. PubMed ID: 1576624
[TBL] [Abstract][Full Text] [Related]
14. Loracarbef (LY163892) versus cefaclor in the treatment of acute bacterial bronchitis.
Dere WH; Farlow D; Therasse DG; Ruoff GE
Clin Ther; 1992; 14(1):41-53. PubMed ID: 1576625
[TBL] [Abstract][Full Text] [Related]
15. Loracarbef. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacy.
Brogden RN; McTavish D
Drugs; 1993 May; 45(5):716-36. PubMed ID: 7686466
[TBL] [Abstract][Full Text] [Related]
16. Effect of loracarbef and amoxicillin on the oropharyngeal and intestinal microflora of patients with bronchitis.
Floor M; van Akkeren F; Rozenberg-Arska M; Visser M; Kolsters A; Beumer H; Verhoef J
Scand J Infect Dis; 1994; 26(2):191-7. PubMed ID: 8036475
[TBL] [Abstract][Full Text] [Related]
17. Loracarbef versus doxycycline in the treatment of acute bacterial maxillary sinusitis. Scandinavian Study Group.
J Antimicrob Chemother; 1993 Jun; 31(6):949-61. PubMed ID: 8360132
[TBL] [Abstract][Full Text] [Related]
18. Comparative United States and European trials of loracarbef in the treatment of acute otitis media.
Foshee WS; Qvarnberg Y
Pediatr Infect Dis J; 1992 Aug; 11(8 Suppl):S12-9. PubMed ID: 1513607
[TBL] [Abstract][Full Text] [Related]
19. Loracarbef versus penicillin VK in the treatment of streptococcal pharyngitis and tonsillitis in an adult population.
McCarty J
Am J Med; 1992 Jun; 92(6A):74S-79S. PubMed ID: 1621750
[TBL] [Abstract][Full Text] [Related]
20. Acute bacterial maxillary sinusitis: results of U.S. and European comparative therapy trials.
Nielsen RW
Am J Med; 1992 Jun; 92(6A):70S-73S. PubMed ID: 1621749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
